What is the current Price Target for the Biomerica, Inc. stock?

The average Biomerica, Inc. target price is $13.26. This is 424.11% higher than the current stock price. The highest price target is 439.53%, the lowest is 418.97%. 3 Analysts have issued a price target Biomerica, Inc. 2027 .

How high will the Biomerica, Inc. stock rise?

No reliable answer can be given as to how high the Biomerica, Inc. stock will rise. The performance of stocks, including the Biomerica, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Biomerica, Inc. stock today?

The performance of Biomerica, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Biomerica, Inc. stock fall?

The decline in Biomerica, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Biomerica, Inc. Forecast, price target & analysts

$2.53

0.40%

Nasdaq, Jan 02, 10:00 pm CET

ISIN

US09061H3075

Symbol

BMRA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Overview Dividends Analysts Charts News Strategies

Biomerica, Inc. Target price 2026 - Analyst rating & recommendation

Biomerica, Inc. Classifications & Recommendation:

Buy

86%

Hold

14%

Biomerica, Inc. Price Target

Target Price	$13.26
Price	$2.53
Potential	424.11% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Biomerica, Inc. 2027 . The average Biomerica, Inc. target price is $13.26. This is 424.11% register free of charge higher than the current stock price. The highest price target is $13.65 439.53% register free of charge , the lowest is $13.13 418.97% register free of charge .
	A rating was issued by 7 analysts: 6 Analysts recommend Biomerica, Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Biomerica, Inc. stock has an average upside potential 2027 of 424.11% register free of charge . Most analysts recommend the Biomerica, Inc. stock at Purchase.

Discover more stocks with a high price target

Coinbase Global, Inc. 72.49%

BioNTech SE - ADR 47.69%

Netflix 47.13%

Adidas 40.14%

Rheinmetall 40.07%

Deutsche Telekom 39.32%

NIO ADR 38.91%

Microsoft 35.87%

Uber Technologies 35.41%

Amazon.com 35.10%

NVIDIA 35.03%

BYD 34.55%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now

The Apple stock at a glance with charts, current key metrics, news and stock analyses.

The Best Dividend Stocks in the Dividend Top Scorer list.

Stock Analyses of the Best Stocks Worldwide.

Start building wealth today